The facility will manufacture filtration systems for biotechnology, pharmaceuticals and blood banking. Pall anticipates double-digit growth in sales for these products over the next three to five years. The Hauppauge plant will double Pall's production capacity.

Pall Corporation specializes in filtration, separation and purification for clients in the biotechnology, pharmaceutical, semiconductor, municipal drinking water, aerospace, blood banking and transfusion industries.

NOT FOR REPRINT

© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.